By submitting your entry, you agree to these terms for yourself and on behalf of your Institution/Company. “You” and “Your” shall refer to you personally or your Institution/Company, as applicable. “We,” “Us,” or “Our” includes Bio-Techne and/or its officers, employees, directors, agents, and affiliates. If you do not agree to these terms, do not click the “SUBMIT” box above, and do not participate in this offer.

Eligibility
Only researchers currently performing basic, translational, or preclinical research projects using stem cells, organoids, spheroids, tumoroids or 3D cell culture within a legally registered research institution, biotech or pharmaceutical organization based in United States, Canada, Mexico, Brazil, Argentina, United Kingdom, Ireland, Germany, France, Spain, Portugal, Italy, Switzerland, Austria, Czech Republic, Belgium, Netherlands, Denmark, Norway, Sweden, Finland, Iceland, Luxembourg, Poland, Japan, Australia, New Zealand, China, Singapore, India, Malaysia, Indonesia, Thailand, Vietnam, or Philippines are eligible to apply.

Practicing healthcare professionals (“HCPs”), individuals subject to the Physicians Payments Sunshine Act, current or former Bio-Techne employees and their immediate relatives are not eligible to receive the grant. For purposes of this program, HCPs include, but are not limited to, physicians, physician assistants, nurses, clinical fellows with patient-care responsibilities, pharmacists with prescribing or purchasing influence, teaching hospitals, or any individual legally defined as a healthcare professional in their jurisdiction.

We reserve the right to reject grant applications for any additional reasons at our sole discretion. No purchase is necessary for entry.

Grant Applications
All applicants must be able to accept free-of-charge reagents on behalf of their institution. All applications must be submitted via the online application form by 6PM ET on November 6, 2026. Applicants must complete the full application form in English. A maximum of 2 applications may be submitted from the same individual. Exceeding this limit will void all submitted applications and you will no longer be eligible to receive a grant.

Judging
All applications will be anonymized and judged in a randomized order.
Three grant winners (one from each region: North America, Europe, Asia/Pacific) will be determined by our team of three Bio-Techne subject experts based on the judging criteria:

• Innovation – does the proposed research incorporate current methods/protocols to push the boundaries of stem cell-based and/or organoid research
• Impact – what impact will the proposed research have on our greater understanding of stem cells, organoids, developmental biology, disease modeling, tissue engineering, cell therapy or regenerative medicine?
• Workflow Application – to what extent will the proposed research utilize multiple relevant reagent portfolios (proteins, small molecules, cell culture products, antibodies and ELISA kits) in the workflow

AI tools may be used to prescreen grant applications based on the same criteria listed above.

Grant Recipients
Grant recipients will be contacted by email and/or phone on or before the November 24, 2026. Winners will be announced publicly the week of December 7, 2026. If for any reason Bio-Techne must delay the winner announcement for any reason, all grant applicants will be contacted by email with updated timelines.

Grant awards will be provided in the form of credits. Grant winners must formally accept the reagent credit within 14 days, or Bio-Techne reserves the right to revoke the offer. Credits may be used to order up to $10,000 (or local currency equivalent at time of award, based on local retail price) of select R&D Systems research reagents (proteins, small molecules, cell culture reagents, media, supplements, extracellular matrices, antibodies, or ELISA kits) from Bio-Techne or affiliated brands (R&D Systems, Tocris or Novus Bio). Offer excludes GMP reagents, custom and special orders, bulk quantities, six packs, and pharm packs, control sets, IVD kits, Luminex reagents, PrimeGene proteins, Valukine ELISA kits, and instruments. Reagent grant credits must be used within 6 months post receipt, placed as a single order, and will be shipped when available.

Any research findings or data generated using grant awards will be solely owned by the grant recipients.

Grant recipients will be asked to provide a photo and quote for the grant winner announcement and may be asked to provide periodic updates on their research project. Participation is entirely voluntary.

Your information will never be sold or used by a third party. See our complete Privacy Policy for more information.